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 Tuberculosis (TB) remains a major global health problem.  In 2012, 8.6 million people 
developed TB and 1.3 million people died from the disease (World Health Organization, 2013).  
Although once thought to have been close to eradication, TB has made a comeback with some 
strains being totally drug resistant (Menzies, Fanning, Yuan, & Fitzgerald, 1995; Udwadia, 
Amale, Ajbani, & Rodrigues, 2012).  Without an immediate pharmacological answer, 
transmission prevention could be the only solution.   
 The World Health Organization (WHO) recommends as a solution that the inpatient wear 
a mask (1999).  However, in the outpatient setting Kuo (2014) found that ineffective pollution 
masks cost Chinese shoppers over 141 million dollars in 2014.  Similarly, while the WHO 
recommends surgical masks for the inpatient with active TB, the WHO recognizes a research gap 
about whether placing surgical masks on inpatients will affect the transmission of TB.  It is the 
purpose of this study to evaluate what effect a non-fit-tested, patient-worn surgical mask would 
have on inpatient transmission rates of TB. 
Theoretical Framework 
 These authors utilized the theoretical framework of Neuman (1980) that postulated strong 
flexible lines of defense facilitate primary prevention.  Current WHO (2009) guidelines suggest 
that a surgical mask may reduce larger droplet formation and minimize the spread of droplet 
nuclei in the chain of infection.  In this application, Neuman’s (1980) theory provides a testable 
framework to determine if a surgical mask will lower TB infection risk by decreasing droplet 
particles.  Application of this theory would also help determine if the vulnerable patient’s defense 
against TB is strengthened by a host-worn surgical mask. The Neuman's Systems Model (1980) 
describes this disease prevention and is perfect for the mask intervention. 
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Literature Review 
 A search was performed on CINAHL, Google Scholar, PubMed, and Medline for journal 
articles within the past five years.  Search terms included tuberculosis, surgical mask, N95, 
performance, transmission, and patient-worn.  A total of 11 articles were examined and six 
articles were retained for review.  Three themes were identified that included mask reliability, 
zone exposure reduction, and actual infection rate reduction. 
Mask Reliability 
 Lai, Poon, and Cheung (2012) found that mask reliability can be affected by the wearing 
arrangement.  When a face mask was reduced from a fully sealed position to a position without 
any artificial seal the protection degree went from near 100% to 33.6%.  However, in examining 
the actual performance between five different surgical masks in reducing vegetative cell 
transmission, Green et al. (2012) found there were no statistical filtration differences observed 
between any of the surgical mask models evaluated (95% CI, 66-76%).  Surgical mask reliability 
in infectious disease prevention varies more by the wearing arrangement than it does by the 
actual model of the mask. 
Zone Exposure Reduction  
 Zayas et al. (2013) found that surgical masks do not reduce the volumetric mean diameter 
and standard deviation of the droplets expelled during a cough (M = 0.30 ± 0.03 µm).  Instead, 
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millions of smaller cough droplets escape the mask and increase the risk for infection.  Zayas et 
al. (2013) suggested that surgical masks can be relied on only to prevent large splashes.  
However, Hui et al. (2012) found that during normal coughing efforts, a surgical mask 
significantly (p = 0.001) reduced air dispersion distance along the median sagittal plane.  This 
finding suggested that while a surgical mask may not halt droplet formation, it might guide 
droplets into a less infectious zone.   
Infection Reduction 
 Albuquerque da Costa et al. (2009) examined the effectiveness of administrative 
measures, which included surgical mask usage by the patient in reducing TB transmission.  
While the infection rates of staff were significantly reduced on the intensive care unit (20.2 to 
4.5, p = 0.001) in the period after the administrative measures, Albuquerque da Costa et al. 
(2009) reported a limitation that the individual measures were not examined for their respective 
contributions.  However, Dharmadhikari et al. (2012) examined the individual impact of a 
patient-worn surgical mask on the infectivity of air as measured by guinea pig infection rates.  
The guinea pigs who breathed air from masked patients had a 2.3-fold (95% CI, 1.5-2.3; p < 
0.005) decreased risk of being infected with TB than those who breathed air from unmasked 
patients.  Patient-worn masks provided a 56% (95% CI, 33-71%) reduced risk of transmission.   
 Current literature is limited in answering the TB transmission surgical mask question.  
Much of the current literature is lower level evidence such as lab tests or animal studies.  Those 
studies incorporating surgical mask usage by the patient, have failed to report the individual 
effect the mask usage produced (Albuquerque da Costa et al., 2009).  While Green et al. (2012) 
found some promising mask reliability, there are efficacy limitations to be considered with mask 
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usage (Lai, Poon, & Cheung, 2012).  Some benefit was reported by Hui et al. (2012) that 
included aiming the infectious droplets another direction.  However, Zayas et al. (2013) 
suggested this infection prevention benefit could be equally obtained with an arm or hand.  
Current literature does not adequately answer whether patient-worn surgical masks are effective 
in TB prevention.   
Methods 
Study Design and Population Sample 
 In this randomized, controlled experimental study (to determine the effect of a patient-
worn, non-fit-tested surgical mask on inpatient TB transmission rates), a convenience sample of 
both adult men and women will be recruited for two years from both the staff and patients on two 
units at the National Institute of Tuberculosis and Respiratory Diseases located in New Delhi, 
India.  The experiment independent variable will be a patient-worn, non-fit-tested Green ear-loop 
face mask (Dental Warehouse, Pretoria, South Africa).  Active TB patients admitted to the units 
will not wear a mask during the first year of the study.  During the second year, the mask will be 
worn by all the active infection TB patients throughout their stay at the facility.  Uninfected 
patients and staff will be tested two weeks upon discharge and monthly for their exposure rates 
Infection rates are defined as a positive T-spot lab test.    
 The study sample will consist of direct-care providers and patients unexposed to TB but 
who are admitted to the facility for other reasons.  Notices regarding the study will be placed at 
all entrance points of the two units in the National Institute of Tuberculosis and Respiratory 
Diseases.  Patients will be screened upon admission to the facility.  If criteria is met, the patient 
will be admitted to one of the two units.  Participants will be enrolled in the study if they are 
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cognitively intact, medically stable, and capable of providing written informed consent (see 
Appendix A).  This study will exclude patients who have been medically determined to be 
immunodeficient and will exclude those under the age of 18.  In addition, those patients who 
have were born outside of India will be excluded.  Direct-care staff will be eligible to work on 
the unit if they volunteer to be a part of the study. 
Ethics 
 In order to respect human dignity, a full intervention protocol and informed consent will 
be submitted to the Southern Adventist University Institutional Review Board for approval. 
Subsequently to assure the protection of the participants and provide transparency of study 
procedures, all participants and patients admitted to the two units will be asked to sign an 
informed consent prior to participating in the study (see Appendix A).  In addition, direct-care 
staff and uninfected patients will be allowed to utilize their standard-of-care TB protection 
First Year
(Aug. 2015-Dec. 2016)
First Year 
(Dec. 2015-2016)
Second Year 
(Dec. 2016-2017)
Data Analysis
(Dec. 2017-study 
completion)
Fund-raising will begin
August 2015
Identified TB Patients 
wear no masks
 (no intervention)
Identified TB Patients 
wear surgical mask
(Intervention)
Infection rates of both 
staff and uninfected 
patients grouped and 
compared before and 
after (Comparison)
Flyers will be posted 
outside of the hospital 
and TV/Radio 
announcements will 
begin  (Recruitment)
Staff utilizes standard 
protection measures 
and checked monthly 
for TB (Data collected)
Staff continues standard 
protection measures 
and checked monthly 
for TB (Data collected)
Data will be compared 
using SPSS.
(Comparison)
Eligible staff and TB 
patients selected.
(Screening)
Uninfected patients 
utilized standard 
protection measures
and checked two weeks 
after discharge for TB
(Data collected)
Uninfected patients 
continue standard 
protection measures 
and checked two weeks 
after discharge for TB
(Data collected)
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equipment such as N95 respirators, standard precautions and negative pressure isolation.  Finally, 
the study will be conducted according to the Helsinki Declaration (2008).   
Measurement 
 The T-Spot TB test will be utilized to assess for any infectious exposure to TB in the 
direct-care staff, uninfected patient populations, and active TB populations.  According to Leung 
et al. (2010), “A positive T-Spot TB test significantly predicted the subsequent development of 
active TB (relative risk, 4.50; 95% confidence interval, 1.03-19.68) and culture- or histology-
confirmed TB (relative risk, 7.80; 95% confidence interval, 1.02-59.63)” (p. 834).  Subject’s 
blood will be collected and analyzed utilizing this blood test.  Masked, active TB patients will be 
confirmed by a medical evaluation performed by two physicians present on the units.   
Data Collection 
 Data collection will begin after approval is obtained from Southern Adventist 
University’s institutional review board.  Blood will be collected by a trained phlebotomist and 
will be taken to the hospital lab utilizing standard procedures.  Data collection will begin 
December 2015 and end December 2017.  Data collection will occur monthly on participating 
unit staff and will occur on uninfected patients two weeks after discharge.   
Data Analysis 
 Data analysis will be performed using IBM SPSS version 22.0.  Baseline demographic 
data will be included for describing the population.  Because the unit will utilize the same patient 
population for both before and after the intervention, the infection rates in the first year will be 
compared to infection rates in the second year by utilizing a paired t-test (or the nonparametric 
equivalent).  Descriptive statistics will be utilized to describe baseline data.  The independent 
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variable of patient-worn mask usage will analyzed for affecting the dependent variable of 
inpatient transmission of TB.   
Conclusion 
 At the end of this study, the researchers hope to understand what effect a patient-worn 
mask has on inpatient TB transmission rates.  It is the researcher’s hope to utilize this 
information to determine if patient-worn surgical masks are cost-effective environmental 
measures for hospitals to utilize.  This information could also fill the research gap mentioned by 
the WHO and determine if these recommendations should be more broadly implemented in light 
of actual experimental evidence.   
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Appendix A 
Consent Form for Participation in Research Study 
Southern Adventist University 
Researcher(s):  xxx 
Study Title: Patient-worn surgical mask TB infection prevention study 
  
Funding Agency:  Southern Adventist University Nursing Program 
1. WHAT IS THIS FORM? 
This form is called a Consent Form. It will give you information about the study so you can 
make an informed decision about participation in this research.  This consent form will give you 
the information you will need to understand why this study is being done and why you are being 
invited to participate.  It will also describe what you will need to do to participate and any known 
risks, inconveniences or discomforts that you may have while participating.  We encourage you 
to take some time to think this over and ask questions now and at any other time.  Should you 
agree to participate, you will be asked to sign this form and you will be given a copy for your 
own personal records.  
2. WHO IS ELIGIBLE TO PARTICIPATE? 
Any person who is cognitively intact, medically stable, capable of reading or understanding 
English fluently, and provides written informed consent.  Subjects must be at least 18 years old 
to participate.  
3. WHAT IS THE PURPOSE OF THIS STUDY? 
The purpose of this research study is to determine the efficacy of a green face loop patient-worn 
non-fit-tested surgical mask in preventing TB transmission on an inpatient respiratory unit in 
New Delhi, India.   The care team will include two physicians, a phlebotomist, and the laboratory 
staff.  
  
4. WHERE WILL THE STUDY TAKE PLACE AND HOW LONG WILL IT LAST? 
The research study will take place in New Delhi, India at the National Institute of Tuberculosis 
and Respiratory Diseases.  A T-Spot blood test will be checked on participating staff monthly and 
uninfected patients will be checked two weeks after discharge.  At the end of the study the 
researchers will cease contact with you.    
5. WHAT WILL I BE ASKED TO DO? 
If you agree to take part in this study, you will be asked to continue with current TB prevention 
guidelines as recommended by the CDC.  You will be asked to provide blood monthly if your are 
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a staff member.  If you are a patient, you will return to the facility two weeks after discharge for 
a follow-up blood specimen.  You will also have the right to refuse any treatment that the 
physician suggests for you.  If you are an active TB inpatient, you will be asked to not wear a 
surgical mask during the time period of December 2015-2016.  If you are an active TB inpatient 
you will be asked to wear a mask during the time period of December 2016-2017.    
6. What are my benefits of being in this study?  
By participating in this study, you may gain benefits by being selected for the intervention group 
and having your risk for contracting TB assessed, evaluated, and treated, if needed.  You will 
gain knowledge on how to decrease your risk for contracting TB.  Additionally, this study will 
benefit society in general, as it provides advancement of knowledge on whether masks should be 
utilized in preventing TB transmission. 
7.  WHAT ARE MY RISKS OF BEING IN THIS STUDY?  
There is a risk that you could be exposed to a potentially increased infectious environment.  
There is potential that the unit you are admitted to could have increased infectious particles in the 
air.  However, your exposure will be reduced utilizing the standard-of-care precautions such as 
N95 masks, negative pressure rooms, and current pharmacological standards.  The 
multidisciplinary team is formed to help you through your healing and recovery process.    
Additionally, there is the possible inconvenience of the time it takes to complete the study. 
Obtaining blood products can potentially cause some minor pain and increase risk for infection 
and bleeding.   
8. HOW WILL MY PERSONAL INFORMATION BE PROTECTED? 
The following procedures will be used to protect the confidentiality of your study records. There 
will be paper records from the T-Spot lab results as well as electronic files of patient’s 
demographics and assessments, all of which will be kept by the researchers in a secure location, 
either by locked file cabinet or a password-protected computer file.  Only the researchers will 
have keys to the locked file cabinets and a master key that links names and codes will be kept in 
a separate and secure location.  The master key and the surveys will be destroyed five years after 
the study closes.  Any computer hosting research files will also have password protection to 
prevent access by unauthorized users.   Only the members of the research staff will have access 
to the passwords.  The computer files will be deleted and the computers reset five years after the 
study closes.  At the conclusion of this study, the researchers may publish their findings. 
However, information will be presented in summary format and you or your personal 
information will not be identified in any publication or presentation. 
9. WHAT IF I HAVE QUESTIONS? 
Please read the informed consent thoroughly before you make a decision.  We will be happy to 
answer any question you have about this study.  If you have any further questions about this project 
or if you have a research-related problem, please contact the researchers, James Bowen or Austin 
Greenwood at 423-339-xxx or 423-693-xxxx.  If you have any questions concerning your rights as a 
research subject, you may contact the Southern Adventist University Institutional Review Board 
(IRB) at 423-236-xxxx or IRB@southern.edu 
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10. CAN I STOP BEING IN THE STUDY? 
You do not have to be in this study if you do not wish to.  If you agree to be in the study, but later 
change your mind, you may drop out at any time.  There are no penalties or consequences of any 
kind if you decide that you do not want to participate.  However, we highly recommend reading the 
consent thoroughly and asking questions if you have them, in order to promote good results of the 
study. 
11.WHAT IF I AM INJURED? 
Southern Adventist University does not have a program for compensating subjects for injury or 
complications related to human subjects research, but the study personnel will assist you in 
getting treatment, should injury take place.  However, we do not anticipate any subject becoming 
physically injured.  
12. SUBJECT STATEMENT OF VOLUNTARY CONSENT 
When signing this form I am agreeing to voluntarily enter this study. I have had a chance to read 
this consent form, and it was explained to me in a language, which I use and understand. I have 
had the opportunity to ask questions and have received satisfactory answers. I understand that I 
can withdraw at any time. A copy of this signed Informed Consent Form has been given to me. 
________________________  ____________________  __________ 
Participant Signature Print Name   Date 
By signing below I indicate that the participant has read and, to the best of my knowledge, 
understands the details contained in this document and has been given a copy. 
_________________________    ____________________  __________ 
Signature of Person  Print Name   Date 
Obtaining Consent 
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Nursing Research Matrices 
James Bowen 394185 (final three articles) & Austin Greenwood (first three articles) 
Reference Problem 
Purpose 
Hypothesis
Patients 
Populations 
Sample
Interventions  
Identify 
Independent and 
Dependent 
Variables
Comparisons Outcomes/
Findings
Level 
of 
Eviden
ce
Dharmadhika
ri, A. S., 
Mphahlele, 
M., Stoltz, 
A., Venter, 
K., 
Mathebula, 
R., Masotla, 
T., ... & 
Nardell, E. A. 
(2012). 
Surgical face 
masks worn 
by patients 
with 
multidrug-
resistant 
tuberculosis: 
impact on 
infectivity of 
air on a 
hospital 
ward. 
American 
journal of 
respiratory 
and critical 
care 
medicine, 
185(10), 
1104-1109.
Problem: Drug-
resistant 
tuberculosis 
transmission in 
hospitals 
threatens staff 
and patient 
health. Surgical 
face masks used 
by patients with 
tuberculosis are 
believed to 
reduce 
transmission but 
have not been 
rigorously tested 
Objective:  The 
objective of this 
study was to 
determine if 
wearing a 
surgical mask 
would decrease 
the 
infectiousness of 
the environment 
Hypothesis:  A 
surgical mask 
worn by the 
patient may stop 
some portion of 
larger respiratory 
droplets expelled 
from the mouth 
or nose by 
breathing, 
coughing, 
sneezing, or 
talking from 
becoming 
infectious droplet 
nuclei.   
Patients:  17 
patients were 
selected 
including eight 
men and nine 
women. 
Populations:  
The 17 patients 
were admitted 
for MDR-TB 
treatment 
initiation 
according to 
South African 
Guidelines 
between May 
and August 
2010.   
Sample:  
Patients were 
included if they 
could tolerate 
mask wearing 
for extended 
periods of time, 
were coughing, 
and had no 
contraindication
s to mask usage.   
IV:  The wearing 
of a green ear-
loop face mask 
(Dental 
Warehouse, 
Pretoria, South 
Africa)   
Patients could 
obtain a new 
mask anytime  the 
mask they were 
wearing became 
soiled, 
moist,deformed, 
or otherwise 
unwearable or 
uncomfortable. 
Masks were 
removed for 
meals and 
medications and 
not worn during 
sleep or between 
7:00 P.M. and 
7:00 A.M.   
Masks were worn 
on alternating 
days by the entire 
patient 
population. 
DV:  Air was 
pumped on 
alternating days 
into two groups of 
guinea pigs.  The 
first group of 
guinea pigs was 
pumped air from 
the total 
population 
infected with 
tuberculosis that 
was wearing 
masks.  The 
second group of 
guinea pigs was 
pumped air on an 
alternating day 
when no masks 
were worn.  
The infection 
rates of the two 
guinea pig 
groups were 
compared to 
determine what 
effect the mask 
had on 
protecting the 
air pumped to 
the guinea pigs.   
First group of 
guinea pigs who 
breathed non-
masked air was 
compared with 
the second 
group of guinea 
pigs who 
breathed air that 
was coming 
from an 
environment 
where masks 
were worn.  
Prior to testing, 
all guinea pigs 
tested 
nonreactive to 
PPD skin testing.   
The guinea pigs 
who breathed air 
from masked 
patients had a 
2.3-fold (95% 
CI, 1.5-3.4; 
P<0.005) lower 
risk among 
guinea pigs than 
from those 
guinea pigs who 
breathed air from 
unmasked 
patients.   
Mask usage 
provided a 56% 
(95% CI, 
33-71%) risk 
reduction in 
transmission.  
Level 
of 
Evide
nce: 
III 
(Quasi
-
experi
mental 
study) 
This 
study 
combi
ned 
both 
animal 
and 
human 
subjec
ts.  
Howe
ver, 
there 
was a 
clear 
prospe
ctive 
cohort 
design
.
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Lai, A. C. K., 
Poon, C. K. 
M., & 
Cheung, A. 
C. T. (2012). 
Effectiveness 
of facemasks 
to reduce 
exposure 
hazards for 
airborne 
infections 
among 
general 
populations. 
Journal of 
The Royal 
Society 
Interface, 
9(70), 
938-948.
Problem:   
Scientific data 
on 
effectiveness of 
face masks in 
reducing 
infections in 
the community 
are extremely 
limited and 
even 
inconsistent. 
Purpose:  The 
purpose of this 
study was to 
assess the 
performance of 
facemarks in 
providing 
protection under 
various 
environmental 
conditions and 
human factors. 
Hypothesis:  A 
direct hypothesis 
in this study was 
not immediately 
clear.   
The implied 
hypothesis was 
that a face mask 
would decrease 
infection rates.  
This study was a 
lab experiment 
and as such did 
not have a 
population or 
sample except 
for the two 
manikins that 
were labeled as 
source and 
susceptible.  
IV:  The source 
manikin was 
covered with a 
face mask.  Four 
face mask 
wearing 
conditions were 
mimicked to 
represent different 
ways people 
might wear 
facemarks.   
The first was a 
fully sealed face 
mask, regarded as 
the ideal case, 
where all sides 
were sealed onto 
the manikin’s face 
by double-sided 
tape.   
The second was a 
three-side-sealed 
facemark, where 
three sides were 
sealed and the 
upward side was 
shaped in a 
normal way to 
mimic natural 
wearing.   
The third wearing 
condition was 
also a three-side-
sealed face mask, 
but with a 4 mm 
artificial leakage 
on both sides of 
nose.   
The last one was 
the closest to the 
normal wearing 
pattern as no 
artificial seal or 
leakage was 
applied.   
Polydisperse 
sodium chloride 
particles were 
generated by a 
spray gun which 
then impacted the 
manikin wearing 
the mask.   
DV:  The 
outcome was 
measured by the 
number of 
particles detected 
The penetration 
of the particles 
was compared 
on the four face 
mask conditions 
of the receiver 
manikin 
In addition, 
velocity and 
distance were 
also explored to 
determine what 
effect these had 
on the 
protection 
coefficient of 
the mask  
The wearing 
arrangement of a 
facemask was 
shown to have a 
significant 
influence on the 
protection 
coefficient of the 
mask.   
The normal 
wearing pattern 
provided the 
lowest amount of 
protection.  The 
highest 
expiratory speed 
reduced the 
protection 
coefficient to 
33.6 percent.   
The distance 
factor had the 
greatest impact 
on the 
effectiveness of 
the mask.  The p 
value of distance 
is the smallest 
with the 
significant 
confidence (less 
than 0.05) 
compared with 
velocity and 
duration.   
It was found that 
for a completely 
sealed mask, 
emission 
velocity, 
duration, and 
distance do not 
affect the 
exposure at the 
mouth.   
Fully sealed 
facemasks 
provide the 
highest level of 
protection.  
Level 
of 
eviden
ce: VII 
Lab 
experi
mental 
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Zayas, G., 
Chiang, M. 
C., Wong, 
E., 
MacDonald, 
F., Lange, C. 
F., 
Senthilselva
n, A., & 
King, M. 
(2013). 
Effectivenes
s of cough 
etiquette 
maneuvers 
in disrupting 
the chain of 
transmission 
of infectious 
respiratory 
diseases. 
BMC public 
health, 
13(1), 811.
Problem: 
There is a 
lack of 
evidence 
suggesting 
that measures 
such as 
“cover your 
mouth when 
coughing” 
will cause 
disruption in 
the chain of 
respiratory 
disease 
transmission.    
Purpose:  The 
purpose of this 
study was to 
determine the 
effectiveness of 
cough etiquette 
maneuvers in 
blocking droplets 
expelled as 
aerosol during 
coughing. 
Hypothesis:  
Covering the 
cough of a 
patient will 
prevent aerosol 
from forming 
and decrease 
infectiousness of 
the air.  
Patients: 
A total of 31 
health adults 
who were ages 
18 and older 
participated.   
All participants 
were self-
identified as 
non-smokers, 
with the 
exception of one 
male who 
declared he was 
a long-term 
(30+ years) ex-
smoker.   
A control group 
of 44 
participants was 
also included 
Population 
None of the 
participants 
declared having 
asthma, cystic 
fibrosis, or the 
respiratory 
conditions.  
Participants 
were excluded if 
they had 
received 
expectorants, 
mucolytics, or 
natural products 
for respiratory 
conditions 
during the 
previous 30 
days or had 
developed flu-
like symptoms 
immediately 
before the study.   
Sample 
Participants 
were recruited 
through 
advertised 
leaflets in public 
areas around the 
university 
campus in 
Alberta, 
Canada.  
IV: 
The intervention 
was covering the 
mouth and nose 
with the hands, 
sleep/arm, tissue, 
or while wearing 
a surgical mask.   
DV:  The 
outcome of how 
many droplets 
were released or 
diverted were 
quantitatively 
characterized to 
assess how 
effective those 
maneuvers are in 
controlling the 
cough aerosol jet.  
Measurement 
time per 
maneuver was 10 
seconds 
The outcome was 
measured using a 
He-Ne laser 
diffractometer to 
determine the 
droplet 
concentration of a 
single cough 
event crossing the 
measurement 
zone every 0.4 
milliseconds 
during a manually 
triggered time of 
10 seconds.  
The control was 
compared to the 
surgical mask, 
hand, tissue and 
sleeve to 
determine the 
average amount 
of droplets 
aerosolized as 
measured by the 
laser 
diffractometer.
Findings: 
The average 
volumetric mean 
diameter and standard 
deviation of the 
droplets expelled as 
aerosol when 
coughing that crossed 
the measurement 
volume zone per CE 
maneuver is as 
follows: sleeve 0.31 ± 
0.06 μm, tis- sue 0.30 
± 0.02 μm, hands 0.30 
± 0.04 μm, and 
surgical mask 0.30 ± 
0.03 μm. The standard 
deviation in the size 
distribution is of the 
average volumetric 
mean diameter. 
Respiratory 
hygiene/cough 
etiquette 
maneuvers do not 
block or contain 
cough droplets 
expelled as aerosol 
from dispersing.  
Droplets smaller 
than one-micron 
size dominate the 
total number of 
droplets released 
when practicing 
cough etiquette.  
All the assessed 
cough etiquette 
maneuvers have 
the potential to 
permit airborne 
transmission of 
respiratory 
infections.  All the 
cough/hygiene 
etiquette allow the 
spread of epidemic 
outbreaks, instill a 
false sense of 
security and merit a 
critical review
Level 
of 
eviden
ce:  
This 
study 
was a 
experi
mental 
study 
and 
falls 
under 
level 
III.  
This 
was a 
prospe
ctive 
study 
in 
which 
there 
was a 
clear 
control 
group 
compar
ison.  
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Hui, D. S., 
Chow, B. K., 
Chu, L., Ng, S. 
S., Lee, N., 
Gin, T., & 
Chan, M. T. 
(2012). 
Exhaled air 
dispersion 
during 
coughing with 
and without 
wearing a 
surgical or 
N95 mask. 
PloS one, 
7(12), e50845.
Problem: 
There is limited 
data on the 
aerodynamics of 
coughing with 
and without 
coverage by 
standard 
facemarks in the 
clinical setting. 
Purpose & 
Objective:  The 
purpose and 
objective of this 
study was to 
determine what 
effect a surgical 
mask or N95 
mask had on 
arresting cough 
particles in a 
negative pressure 
isolation room.   
Hypothesis:  An 
implied 
hypothesis was 
present and this 
was that wearing 
a mask would 
arrest droplets 
and reduce 
infectious 
transmission 
This study was a 
lab experiment 
and did not have 
a sample human 
population.  
However, there 
was a human 
patient 
simulator that 
represented a 
70-kg adult 
male sitting on a 
45 degree 
inclined hospital 
bed.  A realistic 
airway and lung 
model was used 
to simulate 
realistic 
respiration.    
Smoke was fed 
through the 
device and was 
measured to 
simulate 
dispersion.  
IV:  The 
intervention was 
the use of a 
surgical mask 
(Safe Mask AR 
Medicom Inc. 
Asia)  or a N95 
mask (M1860, 3 
M, MN, USA) 
DV:  The 
outcome of 
smoke plumes 
was measured 
using a high 
definition video 
camera that had 
an optical 
resolution of 
1,440 x 1,080 
pixels per video 
frame.  
“We compared 
the distance and 
direction of 
expelled air 
during coughing 
with and 
without 
coverage by a 
surgical mask 
and a N95 mask 
in a hospital 
isolation room 
with negative 
pressure.” 
Findings: 
During normal 
coughing efforts 
when the HPS 
was lying at 45 
degrees on the 
bed, the average 
exhaled air 
dispersion 
distance along 
the median 
sagittal plane 
was 68.0 6 6.5 
cm without a 
facemask. This 
was significantly 
reduced by 
wearing a 
surgical mask 
(30.0 6 3.4 cm) 
or N95 mask 
(15.1 6 2.7 cm), 
p , 0.001 (Fig. 2).  
With tight 
application of the 
N95 mask, there 
was less expelled 
air leakage 
through the nasal 
bridge to the 
upward direction 
(Fig. 4). The 
corresponding 
lateral dispersion 
distance when 
wearing a 
surgical mask 
was 27.9 6 2.6 
cm whereas N95 
mask 
significantly 
reduced the 
lateral dispersion 
to 15.0 6 1.7 cm, 
p , 0.001 (Fig. 4) 
Level 
of 
Eviden
ce: 
This 
level 
was 
VII 
and is 
consid
ered a 
lab 
study.
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Green, C. F., 
Davidson, C. 
S., Panlilio, A. 
L., Jensen, P. 
A., Jin, Y., 
Gibbs, S. G., 
& Scarpino, P. 
V. (2012). 
Effectiveness 
of selected 
surgical masks 
in arresting 
vegetative 
cells and 
endospores 
when worn by 
simulated 
contagious 
patients. 
infection 
control and 
hospital 
epidemiology, 
33(5), 
487-494.
Problem:  This 
article did not 
clearly identify 
the problem.  
However, the 
problem was 
implied by first 
stating that 
current cough 
etiquette calls for 
source-control 
measures such as 
covering a 
coughing person 
with a surgical 
mask.  The 
research gap was 
implied by the 
purpose 
statement in that 
not enough 
research has 
been performed 
on the efficacy of 
the surgical mask 
in controlling 
infection 
transmission.   
Purpose & 
Objective: 
The objective of 
this study was to 
quantify the 
effectiveness of 
selected surgical 
masks in 
arresting 
vegetative cells 
and endosperm 
in an 
experimental 
model that 
simulated 
contagious 
patients 
Hypothesis:  The 
hypothesis is that 
wearing a 
surgical mask 
will place a 
barrier in the 
chain of 
transmission by 
preventing 
microorganism 
transmission.
This study was a 
lab experiment 
and did not have 
a patient 
population, 
sample, or 
sampling. 
However, this 
study made use 
of mannequins 
that were 
retrofitted with 
a nebulizer that 
was set a tidal 
volume of 
500ml/breath.  
Five types of 
surgical masks 
were fitted to 
the mannequin 
and challenged 
with endospores 
and other 
biological 
matter.   
IV: 
The intervention 
in this study were 
the five surgical 
masks that met a 
bacterial 
efficiency 
filtration test of 
four micrometers 
in diameter.  
The masks 
models were the 
3M 1818, the 3M 
1818FS, the 
Kimberly Clark 
48201, the 
Kimberly Clark 
48208, and the 
Medline 
NON27402 
  
DV: 
The dependent 
variable or 
outcome 
measured was the 
amount of 
endospores and 
vegetative cells 
that penetrated 
the masks.  
Bacillus anthracis 
was used to 
challenge the 
masks.  
The 
performance of 
the five masks 
in filtering the 
endospores and 
other vegetative 
matter was 
compared. 
The masks were 
placed on the 
mannequins in a 
bioaerosol 
chamber.  A 
nebulizer was 
turned on for 8 
minutes to allow 
the chamber to 
reach a steady 
state.  Sampling 
was then 
accomplished 
by collecting 
bioaerosol 
samples that 
were outside the 
mask in the air 
chamber.   
Findings: 
There were no 
statistical 
differences 
observed 
between any of 
the surgical mask 
models evaluated 
for the arrestance 
of vegetative 
cells. 
When 
considering 
endospores, the 
Kimberly Clark 
48201 model 
was statistically 
lower than that 
by the 3M 1818, 
the 3M 1818FS, 
and the Medline 
NON27402 
models. The 
arrestance values 
by Kimberly 
Clark 48201 and 
Kimberly Clark 
48208 were not 
statistically 
different from 
each other. The 
arrestance values 
by 3M 1818, 3M 
1818FS, Medline 
NON27402, and 
Kimberly Clark 
48208 were not 
statistically 
different from 
each other.
A reduction in 
particle size (> or 
= to 1 
micrometer) was 
observed in the 
masks.  The 
change in size 
distribution was 
observed to be 
consistent with 
the arsenate of 
larger “wet” 
particles, with 
fewer large 
particles being 
left to become 
smaller droplet 
Level 
of 
Eviden
ce: VII  
This is 
an 
experi
mental 
lab 
study.  
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Albuquerque da 
Costa, P., 
Trajman, A., 
Carvalho de 
Queiroz Mello, 
F., Goudinho, 
S., Monteiro 
Vieira Silva, M. 
A., Garret, 
D., ... & Lineu 
Kritski, A. 
(2009). 
Administrative 
measures for 
preventing 
Mycobacterium 
tuberculosis 
infection among 
healthcare 
workers in a 
teaching 
hospital in Rio 
de Janeiro, 
Brazil. Journal 
of Hospital 
Infection, 72(1), 
57-64.
Problem: 
Nosocomial 
transmission of 
tuberculosis has 
been difficult to 
control.  The role 
of individualized 
infection control 
measures has not 
been established.   
Purpose & 
Objective: 
The objective of 
this study was to 
evaluate the 
impact of 
administrative 
measures for 
control of 
tuberculosis 
transmission in a 
teaching hospital 
in Rio de 
Janeiro.   
Specific 
relevance:  
Patients leaving 
the room for 
diagnostic tests 
were required to 
wear a protective 
surgical mask, 
and were 
educated on 
cough etiquette 
and respiratory 
hygiene by the 
ward nurse.  
Hypothesis:  The 
implied 
hypothesis is that 
the 
administrative 
measures applied 
will reduce 
nosocomial 
tuberculosis 
infections to 
healthcare 
workers.   
Patient: 
In this study, the 
healthcare 
workers at the 
hospital were 
examined for 
contraction of 
nosocomial 
tuberculosis.   
406 employees 
in the first 
period 
(1999-2001) and 
193 in the 
second period 
(2002-2003) 
were tested.   
Sample:  The 
exact selection 
of the 
employees was 
not completely 
discussed.  
However, the 
sample was 
described to 
include, 
laboratory 
employees, 
nurses, blood 
bank, radiology, 
pathology, 
physicians, 
social services, 
occupational 
and physical 
therapy, 
housekeeping, 
security, 
engineering, 
maintenance, 
laundry, 
nutrition, and 
transportation 
services.  
IV:  The 
administrative 
measures 
included: 
Conversion of 
two-bed rooms 
into isolation 
single rooms 
without negative 
pressure.  Patients 
were placed in 
these rooms when 
a positive culture 
was confirmed.  
Patients with HIV 
and tuberculosis 
were isolated.  
N95 masks were 
required of all 
personnel 
entering the room.  
An educational 
program on TB 
was offered to 
healthcare 
workers.  No fit-
testing of masks 
or respirators was 
performed.  
Specifically 
patients were 
required when 
leaving their 
room to wear a 
protective 
surgical mask and 
were educated on 
cough etiquette.   
DV:  The 
dependent 
variable was the 
outcome of how 
many healthcare 
workers tested 
positive for 
tuberculosis at the 
end of the study.  
The first period 
healthcare 
worker infection 
rates 
(1999-2001) and 
the second 
period 
(2002-2003) 
were compared 
following the 
implementation 
of the 
administrative 
measures.  
Outcome/
Findings: 
25 TST 
conversions were 
observed during 
the first period.  
However, during 
the second 
period only 15 
conversions were 
observed.  In the 
intensive care 
units and clinical 
wards a 
significant 
reduction in risk 
was observed (p 
< 0.001),
Level 
of 
Eviden
ce: 
III  
This 
study 
is a 
quantit
ative 
experi
mental 
study 
that 
evaluat
es the 
outcom
e of a 
populat
ion 
after an 
applied 
interve
ntion.  
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FORM A 
Not required for a literature review/academic exercise. 
RESEARCH APPROVAL 
Research Request: _____Exempt   _____Expedited  ___X__Full Review _____Other 
(Animal/Plant) 
 
Title of Research Project: 
___________________________________________________________________     
Starting Date:  December 5th 2015 Estimated Completion Date: December 10th 
2017
Principal Investigator: James Bowen E-mail Address:  
jamesbowen@southern.edu
Phone #: 423-339-7169
Co-Investigator:   Austin Greenwood E-mail Address: agreenwood@southern.edu
Phone #  423-693-9628
Co-Investigator: E-mail Address:
Phone #:
Co-Investigator E-mail Address:
Phone #:
Department:  Nursing Faculty Supervisor  Jeff Gates
Cooperating Institutions: Is this research being done with any institutions, individuals or 
organizations not affiliated with SAU?  If yes, please provide the names and contact 
information of authorized officials below.
This box is for SAU – IRB Office Use Only 
IRB Tracking #___________ 
Date Received ___________ ______Exempt ______Expedite     _____Full Review     _____Other (Animal/Plant) 
1) IRB Board Approver __________________________    _______________________    ______________  
    Name    Title        Date 
2) IRB Board Approver __________________________    _______________________    ______________  
    Name    Title        Date 
Date Approval Sent____________ 
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Please attach all of the following items, making sure the entire application is completely 
filled out (where applicable) before submitting the application: 
• Any research instruments (tests, surveys, questionnaires, protocols, or any form else used 
to collect data) 
• All informed consent documents 
• Permission from applicable authorities (principals of schools, teachers of classrooms, 
etc.) to conduct your research at their facilities on their School Letterhead. 
• Students need signatures from their faculty advisor. 
 All student applications must be signed by the faculty advisor then scanned and 
submitted electronically, or submitted directly by the faculty advisor. All applications 
should be submitted by email to irb@southern.edu. 
Please be aware you cannot begin your research until it has been officially approved by 
the IRB. 
Type of Research- Check all areas that apply 
____ Dissertation/Thesis  
____ Funded Faculty Research  
____ General Faculty Research  
____ Applying for ARC Funding 
__X__ Student Research 
____ Other:  Animal/Plant 
Background and Rationale for the Study:  (This section should present the context of the work 
by explaining the relation of the proposed research to previous investigations in the field. Include 
citations for relevant research.) 
Name of Institution  National Institute of 
Tuberculosis and Respiratory Diseases
Address:  Near Qutub Minar, Sri 
Aurobindo Marg, Mehrauli, New Delhi, 
Delhi 110030, India
Contact Name:  Dr Rohit Sarin Phone #:  +91 11 2651 7826
Contact E-mail: sa-nitrd@nic.in
External Funding Agency:   N/A/ Identification # ( if applicable)
Grant Submission Deadline (if any)  05/05/2015
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The World Health Organization (WHO) recommends that active infectious TB patients wear a 
mask.  However, the WHO also recognizes a research gap about wether this is effective in 
reducing TB infection rates.  Kuo (2014) found that asian shoppers paid millions for ineffective 
surgical masks in the outpatient setting.  Ineffective surgical masks could be a needless cost for 
TB prevention.   
Purpose/Objectives of the Research:  (Briefly state, in non-technical language, the purpose of 
the research and the problem to be investigated.  When possible, state specific hypotheses to be 
tested or specific research questions to be answered.  For pilot or exploratory studies, discuss the 
way in which the information obtained will be used in future studies so that the long-term 
benefits can be assessed.) 
It is the purpose of this study to determine what effect a non-fit-tested, patient-worn surgical 
mask has on inpatient TB transmission rates.  Our research null hypothesis is that a surgical mask 
will have no effect on TB transmission rates.   
Methods and/or Procedures:  (Briefly discuss, in non-technical language, the research methods 
which directly involve use of human subjects. Discuss how the methods employed will allow the 
investigator to address his/her hypotheses and/or research question(s).) 
TB patients will be asked to not wear a mask for the first year of the study.  Staff will be checked 
monthly for TB exposure and non-infected patients will be checked two weeks after discharge 
using the T-spot lab test.  Infection rates will be compared to the following year at which point 
all TB patients will be required to wear surgical masks during their admission.   
Description of Research Sample: If human subjects are involved, please check all that apply: 
____ Minors (if minors are involved please attach a Childs Assent Form)  
____ Prison Inmates                      
 ____ Mentally Impaired  
____ Physically Disabled 
____ Institutionalized Residents  
____ Anyone unable to make informed decisions about participation 
__X__ Vulnerable or at-risk groups, e.g. poverty, pregnant women, substance abuse population 
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__X__ Health Care Data Information - be sure to attach any necessary HIPAA forms if this 
line is checked 
____ Other: Animals or plants will be used 
____ Other: please describe 
Approximate Number of Subjects: ___500____ 
Participant Recruitment: 
Describe how participant recruitment will be performed.   Include how potential participants are 
introduced to the study (Please check all that apply) 
Content Sensitivity: 
Does your research address culturally or morally sensitive issues?  __X__Yes ____ No   If 
yes, please describe. 
This research will involve one year of not masking infectious TB patients which could make the 
environment more infectious and potentially raise TB infection rates.   
Privacy and Confidentiality: 
Efforts will be made to keep personal information confidential.   We cannot guarantee absolute 
confidentiality.   Personal information may be disclosed if required by law.   Identities will be 
help in confidence in reports in which the study may be published and databases in which results 
may be stored. 
Will personal identifiers be collected? __X__ Yes ____ No  
Will identifiers be translated to a code?  __X__ Yes ____ No 
Will recordings be made (audio, video) ____ Yes _X___ No   If yes, please describe. 
Is Funding being sought to support this research?  _________    
SAU Directory: Postings, Flyers  this will be 
used
Radio, TV  This will be used
E-Mail Solicitation How Were Addresses Obtained
Web-based Solicitation Indicate Site Indicate Site
Participant Pool What Pool
Other, Please Specify
Attach Any Recruiting Materials You Plan to Use and the Text of E-mail or Web-based Solicitations 
You Will Use
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Circle to indicate if the funding is: Internal or External Funding?  Is there a funding risk? 
__External funding_ 
Who will keep the financial records?  ________James Bowen_____________________ 
Who will have access to data (survey, questionnaires, recordings, interview records, etc.)?  
Please list below. 
_______James Bowen and Austin Greenwood_____________________________________ 
Participant Compensation and Costs 
Are participants to be compensated for the study? ____ Yes __X__ No 
If yes, what is the amount, type and source of funds: 
Amount $___________ Type:____________________ Source ______________ 
Will participants who are students be offered class credit? ____ Yes _X___ No ____ 
NA 
Are other inducements planned to recruit participants____ Yes_X___No   If yes, please describe 
Are there any costs to participants? ____ Yes _X___ No   If yes, please explain 
____________________ 
Other:  Animals/Plants 
Are the animals/plants being studied on the endangered list? ____________ 
Are Scientific Collection Permits required, i.e. Tennessee Wildlife Resources Agency? 
__________ 
Have the animal(s) utilized in this study already been used in a previous study (non-naïve 
animals)? ________ 
Will the animal(s) used in this study be used in a future study? ________ 
Where will the animals be housed? _______________________________ 
Will the rodents (if applicable) be housed in wire bottom cages? _______ 
Will plants be used for instructional purposes as part of teaching a course? __________ 
Are there any risks involved with this study?        __X___Yes       ______No 
Are there any potential damage or adverse consequences to researcher, participants, or 
environment?  These might include physical, psychological, social, or spiritual risks whether as 
part of the protocol or a remote possibility.   Please indicate all that apply.   
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__X__ Physical Risk:  May include pain injury, and impairment of a sense such as touch or 
sight.  These risks may be brief or extended, temporary or permanent, occur during 
participation in the research or arise after. 
____ Psychological Risk:  Can include anxiety, sadness, regret and emotional distress, among 
others.  Psychological risks exist in many different types of research in addition to 
behavioral studies. 
____ Social Risk:  Can exist whenever there is the possibility that participating in research or 
the revelation of data collected by investigators in the course of the research, if disclosed 
to individuals or entities outside of the research, could negatively impact others’ 
perceptions of the participant.  Social risks can range from jeopardizing the individual’s 
reputation and social standing, to placing the individual at-risk of political or social 
reprisals. 
____ Legal Risk:  Include the exposure of activities of a research subject “that could 
reasonable place the subjects at risk of criminal or civil liability”. 
__X__ Economic Risk:  May exist if knowledge of one’s participation in research, for example, 
could make it difficult for a research participant to retain a job or find a job, or if 
insurance premiums increase or loss of insurance is a result of the disclosure of research 
data. 
____ Spiritual Risk:  May exist if knowledge of one’s spiritual beliefs or lack of, could be 
exposed which in turn could invoke an economic, social and or psychological risk. 
Risks:  In your opinion, do benefits outweigh risks?  __X__ Yes ____ No 
Results: 
The results will be disseminated as:  
______Classwork only   ______Student conference     ___X___ Professional 
conference         
___X___Published article  ______Other   If other, please specify:  
________________________ 
Signatures: If submitted by a faculty member, electronic (typed) signatures are acceptable.   If 
submitted by a student, please print out completed form, obtain the faculty advisor’s signature, 
scan completed form, and submit it via e-mail.  Only Word documents or PDF files are 
acceptable submissions. 
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James Bowen                                                                 04/04/2015 
Principal Investigator (PI) or Student  Date 
___________________________________  ___________________ 
Faculty Advisor (for student applications)  Date 
All student applications must be signed by the faculty advisor then scanned and submitted 
electronically, or submitted directly by the faculty advisor.   All applications should be 
submitted by email to: irb@southern.edu 
Additional Special Requirements or Attachments to the Application 
  
Approvals from other IRBs 
Cooperative research projects involve research that involves more than one institution. In these 
instances, federal law holds each institution responsible for safeguarding the rights and welfare 
of human subjects and for complying with federal policy; therefore, SAU IRB applications must 
be made even if there is another institution conducting a review of the same research project. 
When a study is being carried out at a non-USA site, and approval from other institutional review 
boards at the foreign site must be sought.  The IRB recommends that a copy of each IRB 
approval be submitted. 
Questionnaires/Other Instruments 
Any questionnaires, tests, survey instruments or data collections sheets which are not standard 
and well known must be submitted as part of the application.  Structured interview questions and 
outlines for unstructured interviews also must be included.   
Advertisements/Notices/Recruitment Flyers 
The text of any advertisement, video display, notice, sign, brochure or flyer used to recruit 
subjects either should be included as an attachment. 
Informed Consent for Participants 
See above.  
